UAE approval for MyLan

We have the pleasure to announce the UAE Ministry of Health & Prevention (MoHAP) approval for; Ricovir-EM® (tenofovir/emtricitabine) 300mg/200mg film-coated Tablets, 30s HDPE bottle Ricovir-EM® is a double combination therapy for the treatment of HIV-1 infected adults. Mylan is committed to manufacturing low-cost, high-quality generics thus contributing to affordable healthcare. Mylan is also involved in […]

Aurobindo

We are pleased to announce Pharma Solutions exclusive partnership with Aurobindo Pharma, one of the largest Pharmaceutical companies in India with a global footprint. Pharma Solutions will exclusively market & distribute Aurobindo Oncology products in key treatment centers in the UAE.

Helsinn Healthcare SA

Retroactive, March 20th, 2018, Helsinn acquired worldwide rights to Valchlor/Ledaga, an alkalyting agent for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) from Actelion Pharmaceuticals Ltd. More details in this link.

UAE Approvals for Mylan

We have the pleasure to announce the UAE Ministry of Health & Prevention (MoHAP) approval for our two new products: Avitaze (efavirenz) film-coated Tablets, 30s HDPE bottle Tenarta (tenofovir) film-coated Tablets, 30s HDPE bottle Avitaze is prescribed for the treatment of HIV. Tenarta is prescribed for the treatment of HBV & HIV. Mylan is committed […]

Pharma Solutions LLC as the exclusive distributor of Les Laboratoires Medis S.A., Tunisia

The UAE MoHAP has endorsed �Pharma Solutions LLC� as the exclusive distributor of �Les Laboratoires Medis S.A., Tunisia�. The following products are governed under this endorsement: Medicaine® 2% solution for injection MP-40® powder & solvent for solution for injection Flukas® 100mg/50ml solution for injection Flukas® 200mg/100ml solution for injection Levoflox® 5mg/ml solution for infusion More […]